. Author manuscript; available in PMC: 2017 Mar 13.

Published in final edited form as: Int J Stroke. 2016 Sep 24;12(2):152–160. doi: 10.1177/1747493016670175

Table 2.

Crude and adjusted hazard ratios (HRs) of all-cause mortality at 30 days, 1 year, and 3 years following ischemic stroke

	Crude HRs	95% CI	Adjusted HRs^a	95% CI
30 days
no-HLD/no-statins^b	1.00		1.00
HLD/no-statins	0.54	(0.40–0.72)	0.65	(0.46–0.92)
HLD/on-statins	0.28	(0.21–0.36)	0.51	(0.37–0.72)
1 year
no-HLD/no-statins	1.00		1.00
HLD/no-statins	0.65	(0.54–0.78)	0.73	(0.59–0.90)
HLD/on-statins	0.44	(0.38–0.52)	0.62	(0.51–0.74)
3 years
no-HLD/no-statins	1.00		1.00
HLD/no-statins	0.72	(0.62–0.84)	0.83	(0.70–0.98)
HLD on-statins	0.52	(0.46–0.59)	0.69	(0.60–0.80)

Adjusted for the patient age, sex, race, BMI, NIHSS score, smoking status, hypertension, diabetes, atrial fibrillation, heart disease, dementia, family history of stroke, prior stroke, prestroke functional status, and antiplatelet and antithrombotic use.

Reference group: no-HLD/no-statins.